Fact CheckerSign in

NCT05469373Active, not recruiting

ESIS in Pediatric DRE

Electrical Stimulation for Seizure Induction in Pediatric Drug-Refractory Epilepsy (ESIS in Pedriatric DRE).

Source: ClinicalTrials.gov · Last updated 1 Oct 2026

Brief summary (registry, in English)

The main reason for this research study is to gain information about how the brain makes seizures by causing seizures using very small amounts of current, or electrical stimulation. Using small amounts of current to cause seizures (or stimulate) is not new at CCHMC - it is part of routine clinical practice for some patients at some electrodes. This study differs from routine clinical care in that all study patients will undergo electrical stimulation in all or nearly all electrode contacts. The study team is doing this because there is promising data in adult patients that stimulating comprehensively (targeting all or nearly all of the electrode contacts) helps define the seizure network. Defining the seizure network in turn helps the medical team plan surgery. So far, there is not as much published data on seizure stimulation for pediatric patients. This research study thus has the potential both to help individual patients (by providing specific information about your seizure networks) and to help pediatric patients with epilepsy in general (by increasing our understanding of stimulated seizures in children, teenagers and young adults).

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
86 (estimated)
First submitted
23 Jun 2022
Start date
17 Feb 2022
Primary completion date
1 Feb 2026
Lead sponsor
Sarah Katie Ihnen
Diseases
Epilepsy
NCT number
NCT05469373

What you commit to

  • Study type: Observational
  • Planned participants: 86
  • From 17 Feb 2022 to the primary completion date, 1 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • \<1 and \>30 years of age

Who the study is looking for

  • Diagnosis of drug-refractory epilepsy (DRE)
  • 1-30 years of age
  • recommended to undergo stereoencephalography (sEEG) at CCHMC

Age in the registry: 1 year to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cincinnati Children's Hospital Medical Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.